FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,117 letters match. Newest first.
-
DrugsAccupack Midwest, Inc.
Accupack Midwest, an over-the-counter drug contract manufacturer, lacked adequate water controls and process validation.
High risk -
FoodRestorative Botanicals, LLC
FDA warns Restorative Botanicals over CGMP failures for two mushroom dietary supplements, including missing identity and toxic-element limits.
Medium -
DrugsWittman Pharma, Inc.
FDA warns Wittman Pharma, an OTC drug maker in Brooksville, Florida, that weak quality oversight and contaminated water make its products adulterated.
High risk -
DrugsAerosol and Liquid Packaging, Inc.
FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.
High risk -
DrugsAromas Para El Alma S.A.
Aromas Para El Alma, a Costa Rica drug manufacturer, made EREWHON hand sanitizer/spray subpotent and broke manufacturing rules.
High risk -
DrugsEnviroServe Chemicals & Cleaners Ltd.
EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.
High risk -
DrugsGreco Gas, Inc.
Greco Gas, Inc. released medical gases without identity or purity testing and without quality oversight.
High risk -
DrugsTJA Health, LLC
FDA warns TJA Health LLC over unsafe drug manufacturing of toothpaste and mouth rinse due to untested components and poor quality control.
High risk -
DrugsAvaria Health & Beauty Corp.
FDA warns Canadian maker Avaria Health & Beauty over CGMP failures in OTC drug products, including skipped ingredient identity testing.
High risk -
DrugsZydus Lifesciences Limited
FDA warned Zydus Lifesciences over cross-contamination and glass particles in its injectable drugs, leading to recalls.
High risk -
DrugsOrean Personal Care Ltd.
FDA warned Orean Personal Care Ltd. that repeat manufacturing failures make its OTC drugs adulterated.
High risk -
DevicesOptikem International, Inc.
FDA cited Optikem International of Denver for unvalidated sterilization and unapproved formulation changes to its Sereine contact lens solutions.
High risk -
DrugsRegenerative Processing Plant, LLC
FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.
High risk -
DevicesWissner-Bosserhoff GmbH
FDA warns German nursing bed maker Wissner-Bosserhoff over quality system failures and an unreported SafeControl handset correction.
High risk -
Food100Misterios, LDA
Portuguese canner 100Misterios' seafood safety plans and sardine canning process controls fall short, FDA says
High risk -
DrugsKaylaan LLC
FDA warns Kaylaan LLC that its fluoride toothpaste tablets were made without release testing, raw material identity testing, and adequate CGMP controls.
High risk -
FoodWaiakea Bottling Inc.
FDA warned Waiakea Bottling that ineffective water treatment and weak process controls led to microbial contamination in bottled water.
High risk -
DrugsAnuMed International, LLC
FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.
High risk -
FoodJ. Moniz Company Inc.
J. Moniz Company, a Massachusetts seafood importer, failed to verify that Portuguese bonito and sardines were processed under seafood HACCP rules.
High risk -
DrugsCARsgen Therapeutics Corporation
FDA warns CARsgen over CGMP violations for investigational CAR T cell products at Durham facility.
High risk -
DrugsEyePoint Pharmaceuticals, Inc.
FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.
High risk -
DrugsEugia Pharma Specialities Limited
FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.
High risk -
DrugsIntercos Europe S.p.A
FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.
High risk -
FoodManabi Export Panama S.A.
FDA cited Panama seafood processor Manabi Export for missing HACCP (food-safety plan) controls on ready-to-eat cooked clam meat in reduced-oxygen packaging.
High risk -
FoodAgustson A/S
Agustson A/S's frozen hot smoked trout fillet plan has serious seafood safety gaps, FDA says.
High risk -
FoodAUSTROFOOD S.A.S.
Austrofood's apple cinnamon puree pouches were adulterated with extremely high lead from cinnamon; hazard controls failed.
High risk -
DrugsLS Promotions Inc.
LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.
High risk -
FoodTxsyn Int. LLC
FDA says Txsyn Int. repackaged dietary supplements without required manufacturing procedures and quality approval.
Medium -
DevicesGlobus Medical, Inc.
FDA warns Globus Medical over Excelsius GPS robot-related misplaced screw complaints and late or missing device reports.
High risk -
DrugsNowrez & Ismail Shukri Company
FDA warns Jordanian OTC drug maker Nowrez & Ismail Shukri over CGMP violations and import alert.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.
High risk -
DrugsGuangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
FDA warned Guangzhou Baiyunshan Jingxiutang Pharmaceutical over current good manufacturing practice violations in over-the-counter drug manufacturing, including inadequate specs and microbial testing.
High risk -
DrugsOmega Tech Labs LLC
Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.
High risk -
DrugsVelocity Pharma LLC
Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.
High risk -
FoodHigh Quality Organics, Inc.
FDA warned High Quality Organics over ready-to-eat spices after finding weak pathogen controls and no pesticide-hazard reanalysis.
High risk -
DevicesCriticare Technologies, Inc.
FDA warns Criticare Technologies over patient monitors after finding unresolved CAPAs, weak design controls and supplier checks at its Warwick, Rhode Island plant.
High risk -
DrugsBrassica Pharma Pvt. Ltd.
FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.
High risk -
FoodFormulation Technology, Inc.
FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.
High risk -
DrugsGenuine Virgin Aloe Corp dba Triderma
FDA warned Triderma, an Anaheim OTC skin cream maker, of CGMP violations after a January 2024 inspection.
High risk -
FoodWest Coast Laboratories, Inc.
FDA warned West Coast Laboratories over dietary supplements made without required manufacturing controls and illegally labeled.
High risk -
DrugsYahon Enterprise Co., Ltd.
FDA warned Yahon Enterprise over manufacturing quality failures for OTC antiseptic wipes after a December 2023 inspection.
High risk -
DevicesJiangsu Shenli Medical Production Co., Ltd.
FDA: Chinese syringe maker Jiangsu Shenli lacked design controls and device master records, halting US imports.
High risk -
DevicesJiangsu Caina Medical Co., Ltd
Jiangsu Caina Medical made Monoject sterile syringes for Cardinal Health but did not properly investigate pump-incompatibility complaints, leading to a Class I recall.
High risk -
DrugsJiangsu Hengrui Pharmaceuticals Co., Ltd.
FDA found data integrity failures and inadequate sterile manufacturing controls at Jiangsu Hengrui Pharmaceuticals' drug facility.
High risk -
DrugsYangZhou SuXiang Medical Instrument Co., Ltd.
FDA warns YangZhou SuXiang Medical Instrument over manufacturing quality failures and import alert for OTC drugs.
High risk -
FoodDiscover Fresh Foods, LLC
FDA found Listeria monocytogenes in Discover Fresh Foods' Easley, SC plant, where refrigerated ready-to-eat dips are made under insanitary conditions.
High risk -
FoodDonggang Wanrui Food Co., Ltd.
Donggang Wanrui Food Co., Ltd. lacked required seafood safety plan monitoring and records for raw frozen octopus and crab.
High risk -
DrugsMax Chemical Inc.
FDA warned Max Chemical Inc. in San Juan, Puerto Rico, that its OTC drug manufacturing violated CGMP, making its drugs adulterated.
High risk -
DrugsARG Laboratories, Inc.
FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.
High risk -
FoodDalian Lingfa Food Co., Ltd.
Dalian Lingfa Food did not control Clostridium botulinum risk in vacuum-packed ready-to-eat bamboo shoots, FDA says.
High risk